Apyx Medical Inc (APYX)

Currency in USD
2.240
-0.010(-0.44%)
Real-time Data·
APYX Scorecard
Full Analysis
Quickly burning through cash
Earnings results expected in 15 days
Fair Value
Day's Range
2.2152.240
52 wk Range
0.7552.730
Key Statistics
Prev. Close
2.25
Open
2.24
Day's Range
2.215-2.24
52 wk Range
0.755-2.73
Volume
4K
Average Volume (3m)
203.12K
1-Year Change
61.87%
Book Value / Share
0.28
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
APYX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
4.000
Upside
+78.57%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Apyx Medical Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

Apyx Medical Inc Company Profile

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company’s helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Apyx Medical Inc SWOT Analysis


Plasma Tech Pionee
Apyx Medical's Renuvion technology offers unique advantages in plastic surgery, with four FDA-approved labels for various applications
Market Headwinds
Explore how economic uncertainties and a soft capital equipment environment are impacting Apyx's revenue, particularly in U.S. generator sales
Financial Resilience
Delve into Apyx's financial performance, including a 60.41% gross profit margin and $48.54 million in trailing twelve-month revenue
Future Prospects
Learn about Apyx's maintained guidance and potential for market expansion as economic conditions improve, with a neutral analyst stance
Read full SWOT analysis

Apyx Medical Inc Earnings Call Summary for Q1/2025

  • Apyx Medical beats Q1 2025 expectations with EPS of -$0.10 vs -$0.12 forecast; revenue at $9.4M vs $9.35M projected
  • Stock rises 4% in aftermarket trading; company appears slightly undervalued with 'FAIR' Financial Health Score
  • Advanced Energy product sales up 6%; gross profit margin increases to 60.1% from 58.1% YoY
  • 2025 revenue guidance: $47.6M-$49M; Advanced Energy revenue expected between $39.6M-$41M
  • Company aims to maintain 60% gross margin, keep operating expenses below $40M; plans AON body contouring platform launch in H2
Last Updated: 08/05/2025, 13:44
Read Full Transcript

Compare APYX to Peers and Sector

Metrics to compare
APYX
Peers
Sector
Relationship
P/E Ratio
−4.2x−5.7x−0.5x
PEG Ratio
−0.24−0.360.00
Price/Book
8.0x3.4x2.6x
Price / LTM Sales
1.8x3.0x3.2x
Upside (Analyst Target)
77.8%48.3%42.7%
Fair Value Upside
Unlock−1.7%5.8%Unlock

Analyst Ratings

1 Buy
2 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 4.000
(+78.57% Upside)

Earnings

Latest Release
May 08, 2025
EPS / Forecast
-0.10 / -0.12
Revenue / Forecast
9.40M / 9.35M
EPS Revisions
Last 90 days

APYX Income Statement

People Also Watch

5.465
CVAC
+0.64%
1.810
IPA
+6.47%
30.42
YOU
+1.91%
56.940
ASTS
-0.26%
127.19
CRWV
-1.99%

FAQ

What Stock Exchange Does Apyx Medical Trade On?

Apyx Medical is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Apyx Medical?

The stock symbol for Apyx Medical is "APYX."

What Is the Apyx Medical Market Cap?

As of today, Apyx Medical market cap is 84.66M.

What Is Apyx Medical's Earnings Per Share (TTM)?

The Apyx Medical EPS (TTM) is -0.54.

When Is the Next Apyx Medical Earnings Date?

Apyx Medical will release its next earnings report on 06 Aug 2025.

From a Technical Analysis Perspective, Is APYX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Apyx Medical Stock Split?

Apyx Medical has split 1 times.

How Many Employees Does Apyx Medical Have?

Apyx Medical has 220 employees.

What is the current trading status of Apyx Medical (APYX)?

As of 23 Jul 2025, Apyx Medical (APYX) is trading at a price of 2.24, with a previous close of 2.25. The stock has fluctuated within a day range of 2.22 to 2.24, while its 52-week range spans from 0.76 to 2.73.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.